Sanofi SA (Nasdaq: SNY) has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves forward with preparations for a possible listing of the business, according to people familiar with the matter.
To read the entire story, you must be logged in.
Please log in now or register with us.
